MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ANIK has $179,387K in assets. $41,020K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
446.25%
Quick Ratio
337.32%
Cash Ratio
195.65%
Unit: Thousand (K) dollars
Assets Breakdown
    • Less accumulated depreciation
    • Cash and cash equivalents
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in-capital
    • Retained earnings
    • Lease liabilities
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
41,020 57,481 57,990 53,167
Accounts receivable, net
25,768 23,690 22,187 23,955
Inventories
22,838 18,787 16,284 16,922
Prepaid expenses and other current assets
3,935 3,400 5,129 5,273
Current assets held for sale
-0 0 0
Total current assets
93,561 103,358 101,590 99,317
Property, plant and equipment, gross
92,475 91,752 --
Less accumulated depreciation
52,753 51,428 --
Property and equipment, net
39,722 40,324 40,684 41,083
Right-of-use assets
25,430 25,939 24,226 24,722
Other long-term assets
4,303 4,034 5,507 5,550
Non-current assets held for sale
-0 0 0
Notes receivable
5,679 5,636 6,478 6,039
Deferred tax assets
1,150 1,275 1,251 1,254
Intangible assets, net
1,650 1,650 1,650 1,661
Goodwill
7,892 8,054 8,051 8,056
Total assets
179,387 190,270 189,437 187,682
Current liabilities held for sale
-0 0 0
Accounts payable
6,339 6,041 4,732 4,771
Accrued expenses and other current liabilities
14,627 15,867 14,357 11,310
Total current liabilities
20,966 21,908 19,089 16,081
Other long-term liabilities
726 701 761 756
Lease liabilities
23,794 24,196 22,782 23,173
Non-current liabilities held for sale
-0 0 0
Common stock, 0.01 par value 90,000 shares authorized, 15,629 issued and 13,357 outstanding and 15,385 issued and 13,889 outstanding at march 31, 2026, and december 31, 2025, respectively
133 139 144 144
Additional paid-in-capital
83,347 87,498 91,105 89,459
Accumulated other comprehensive loss
-5,310 -4,959 -4,939 -4,755
Retained earnings
55,731 60,787 60,495 62,824
Total stockholders equity
133,901 143,465 146,805 147,672
Total liabilities and stockholders equity
179,387 190,270 189,437 187,682
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$41,020K Accounts receivable, net$25,768K Inventories$22,838K Prepaid expenses andother current assets$3,935K Property, plant andequipment, gross$92,475K Total current assets$93,561K Property and equipment,net$39,722K Right-of-use assets$25,430K Goodwill$7,892K Notes receivable$5,679K Other long-termassets$4,303K Intangible assets, net$1,650K Deferred tax assets$1,150K Less accumulateddepreciation$52,753K Total assets$179,387K Total liabilities andstockholders equity$179,387K Total stockholdersequity$133,901K Lease liabilities$23,794K Total currentliabilities$20,966K Other long-termliabilities$726K Accumulated othercomprehensive loss-$5,310K Additionalpaid-in-capital$83,347K Retained earnings$55,731K Accrued expenses andother current...$14,627K Accounts payable$6,339K Common stock, 0.01 parvalue 90,000 shares...$133K

Anika Therapeutics, Inc. (ANIK)

Anika Therapeutics, Inc. (ANIK)